Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent
العنوان: | Long-term outcomes of laparoscopic sleeve gastrectomy from the Indian subcontinent |
---|---|
المؤلفون: | Subodh Kumar, P Praveen Raj, B Deepa Nandhini, S Christinajoice Saminathan, Siddhartha Bhattacharya, Shivanshu Misra |
المصدر: | Obesity Surgery. 29:4043-4055 |
بيانات النشر: | Springer Science and Business Media LLC, 2019. |
سنة النشر: | 2019 |
مصطلحات موضوعية: | Adult, Male, Sleeve gastrectomy, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Population, India, 030209 endocrinology & metabolism, Comorbidity, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Gastrectomy, Weight loss, Diabetes mellitus, Weight Loss, Humans, Medicine, education, Retrospective Studies, Glycated Hemoglobin, education.field_of_study, Nutrition and Dietetics, business.industry, Remission Induction, Type 2 Diabetes Mellitus, Middle Aged, medicine.disease, Obesity, Morbid, Surgery, Indian subcontinent, Diabetes Mellitus, Type 2, Female, Laparoscopy, 030211 gastroenterology & hepatology, medicine.symptom, business, Body mass index, Follow-Up Studies |
الوصف: | Laparoscopic sleeve gastrectomy (LSG) is the most commonly performed metabolic surgery worldwide. There are few mid- to long-term studies for LSG, especially from the Indian subcontinent. The primary outcome of the study was percent total weight loss (%TWL), and secondary outcomes included type 2 diabetes mellitus remission (T2DM) rates, comorbidity resolution rates, revisional surgeries, and complications related to LSG, 3 and 5 years after surgery. The study was a single-center, retrospective analysis from patients who underwent primary as well as revisional LSG between January 2012 and December 2013 from a tertiary care center in India. We included patients who completed a minimum follow-up of 5 years. Details of the patients were collected from outpatient and inpatient case sheet records, during their follow-up. Out of a total of 284 patients, 57% were females. Mean baseline body mass index (BMI) was 44.9 ± 7.9 kg/m2. The diabetic population comprised 14.8% of the total patients. Mean %TWL at 5 years was 26.0 ± 9.9%. T2DM remission at 1, 3, and 5 years were 78.5%, 71.4%, and 66.6%, respectively. Preoperative BMI (p = 0.02), glycosylated hemoglobin (HbA1c) (p = 0.04), duration of diabetes in years (p = 0.04), and preoperative insulin usage (p = 0.04) were the preoperative predictors for T2DM remission. Early ( 30 days) complications were seen in 4.5% and 0.7% of the population, respectively. Weight loss after LSG was maintained in the majority of the patients, while a small proportion has significant weight regain at 5 years. T2DM resolution and other comorbidity resolutions were well supported after LSG. |
تدمد: | 1708-0428 0960-8923 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e46a617bc96f28a90222d6809ccf5f3 https://doi.org/10.1007/s11695-019-04103-z |
حقوق: | CLOSED |
رقم الأكسشن: | edsair.doi.dedup.....6e46a617bc96f28a90222d6809ccf5f3 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 17080428 09608923 |
---|